Stanley-Laman Group’s Axcelis ACLS Stock Holding History

Stanley-Laman Group’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,049	Closed	-$302K	–	271
2021 Q4	$302K	Buy	+4,049	New	+$240K	0.04%	236

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stanley-Laman Group's ACLS Position: Q1 2022 in Review

Stanley-Laman Group sold out of Axcelis (ACLS) in Q1 2022, closing a stake of 4,049 shares — an estimated $302K sold.

Stanley-Laman Group first reported a position in ACLS in Q4 2021 and held it in 1 quarter. The position peaked at $302K in Q4 2021. 290 funds tracked by Wall St. Rank hold ACLS as of Q1 2022.

Stanley-Laman Group reported no remaining Axcelis position as of Q1 2022 after selling out during the quarter.
Stanley-Laman Group sold 4,049 Axcelis shares in Q1 2022, an estimated $302K.
Stanley-Laman Group first reported a position in Axcelis in Q4 2021 and held it in 1 quarter.
Stanley-Laman Group's Axcelis position peaked at $302K in Q4 2021.
290 funds tracked by Wall St. Rank held Axcelis as of Q1 2022.

Based on Stanley-Laman Group's 13F filing for Q1 2022, filed 21 Apr 2022.